Biotechnology Company Reports and Industry Analysis
Looking for up-to-date information on leading biotechnology companies worldwide? MarketResearch.com provides an extensive collection of company profile reports that offer in-depth insights into a company's organizational set-up and key offerings within the biotech industry. These reports serve as valuable resources for identifying prospective clients and partners, as well as gaining a deeper insight into the strengths and vulnerabilities of competitors.
Biotechnology Company Profiles
- Gain expert insights on prominent competitors like Amgen, Roche, Biogen, Gilead Sciences, AstraZeneca, and Pfizer, and more.
- Quickly obtain revenue breakdowns, strategic analysis, and future growth outlooks to inform your own strategies.
- Browse reports from various research firms including GlobalData, MarketLine, Plunkett Research, Current Partnering, and Worldwide Videotex.
Why Choose MarketResearch.com as Your Partner
Whether you are an experienced industry professional looking to improve your strategies, a consultant guiding clients on their next steps, or a busy executive tasked with critical decisions, MarketResearch.com's biotechnology company reports can be your guide in this dynamic landscape. Your competitors are also seeking opportunities, but with insights from MarketResearch.com, you can gain a powerful advantage.
Biotechnology Company Reports Industry Research & Market Reports
-
Puma Biotechnology Inc (PBYI:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Puma Biotechnology Inc (PBYI:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
International Stem Cell Corp (ISCO:PINX): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... compared to its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for International Stem Cell Corp (ISCO:PINX) includes growth forecast for its primary industry for the ... Read More
-
Protagonist Therapeutics (PTGX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... competitors and compared to the average for all companies within its primary industry. This benchmarking study for Protagonist Therapeutics (PTGX:NAS) includes growth forecast for its primary industry for the current year and the next 7 ... Read More
-
Heron Therapeutics Inc (HRTX:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Heron Therapeutics Inc (HRTX:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
Biogen Inc (BIIB:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... competitors and compared to the average for all companies within its primary industry. This benchmarking study for Biogen Inc (BIIB:NAS) includes growth forecast for its primary industry for the current year and the next 7 ... Read More
-
Acorda Therapeutics Inc (ACOR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Acorda Therapeutics Inc (ACOR:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
United Therapeutics Corporation (UTHR:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for United Therapeutics Corporation (UTHR:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
VBI Vaccines Inc (VBIV:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for VBI Vaccines Inc (VBIV:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
Geron Corporation (GERN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... competitors and compared to the average for all companies within its primary industry. This benchmarking study for Geron Corporation (GERN:NAS) includes growth forecast for its primary industry for the current year and the next 7 ... Read More
-
Repligen Corporation (RGEN:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... competitors and compared to the average for all companies within its primary industry. This benchmarking study for Repligen Corporation (RGEN:NAS) includes growth forecast for its primary industry for the current year and the next 7 ... Read More
-
Moderna Inc (MRNA:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... competitors and compared to the average for all companies within its primary industry. This benchmarking study for Moderna Inc (MRNA:NAS) includes growth forecast for its primary industry for the current year and the next 7 ... Read More
-
Gilead Sciences Inc (GILD:NAS): Financial Analysis, Benchmarks Against Industry Averages and Top Competitors, KPIs, EBITDA, Income Statement. Market Size and Growth Forecasts.
... its top competitors and compared to the average for all companies within its primary industry. This benchmarking study for Gilead Sciences Inc (GILD:NAS) includes growth forecast for its primary industry for the current year and ... Read More
-
LXRepair SAS - Product Pipeline Analysis, 2023 Update
... oncology. It develops diagnostic kits to help clinicians to optimize radiotherapy or chemotherapy treatments for cancer. LXRepair's product portfolio includes Glyco-SPOT, ExSy-SPOT and Next-SPOT. Its services comprise of biomarker identification and screening assay services. The ... Read More
-
InVitae Corp (NVTAQ) - Product Pipeline Analysis, 2023 Update
... cancer, women's health, precision oncology, pharmacogenomics and rare diseases. It uses process automation, proprietary design, robotics and bioinformatics software solutions to support genetic counseling, variant interpretation, and clinical trial matching. The company serves payers, healthcare ... Read More
-
OncoNano Medicine Inc - Product Pipeline Analysis, 2023 Update
... detect and treat diseased tissue. OncoNano’s ON-BOARD micelle platform carries a wide variety of payloads for systemic administration to the tumor microenvironment and OMNI platform deliver therapeutic payloads and directly activates a ubiquitous immune signaling ... Read More
-
Antigen Discovery Inc - Product Pipeline Analysis, 2023 Update
... proteome, and others. It provides services such as expert statistical analysis, proteome screening; vaccine development and efficacy monitoring, diagnostic content discovery, biomarker discovery and drug validation, among others. ADI’s proteomics approach enables the identification of ... Read More
-
Tempus Labs Inc - Product Pipeline Analysis, 2023 Update
... centers and community-based hospitals. The company’s major services include genomic sequencing, clinical data structuring, image recognition, biological modeling and TIME Trial technology platform. It also offers clinical decision support services, analytical tools to access, analyze ... Read More
-
Upstream Medical Technologies Ltd - Product Pipeline Analysis, 2023 Update
... CVD, ACS, and others. It provides pipe line product such as Ghr-sp-Pne diagnoses heart failure in the presence of pneumonia; and EPO-sp for detection of kidney failure. It offers products to identify comorbid disease associated ... Read More
-
Delfi Diagnostics Inc - Product Pipeline Analysis, 2023 Update
... is the FirstLook blood test, a laboratory-developed test designed to enhance lung cancer screening. Delfi products are used in the healthcare industry, particularly in routine clinical practice and large-scale clinical trials. Delfi is headquartered in ... Read More
-
Asuragen Inc - Product Pipeline Analysis, 2023 Update
... companion diagnostic services that include commercialization, product approval, development, discovery, partnered research and development and tumor bank programs. Asuragen’s custom reagents comprise armored reagents in vitro transcribed RNA and plasmid DNA kits. The company distributes ... Read More
-
ZiP Diagnostics Pty Ltd - Product Pipeline Analysis, 2023 Update
... (SARS-CoV-2); ZiP-CoVx-T1 and ZiP-CoVx-C2 test systems that incorporate ZiP-CoVx assay to diagnose coronavirus. The company is also designing ZiP CT-NG, a molecular diagnostic test system targeting chlamydia and gonorrhea. Zip Diagnostics utilizes point-of-care (PoC) systems ... Read More
-
Ignite Biomedical Inc - Product Pipeline Analysis, 2023 Update
... data from complex non-linear systems which produces unbiased and accurate predictive algorithms. It is developing its biomarker blood test pipeline in therapeutic areas of rheumatoid arthritis, irritable bowel disease, and behavioral health. Ignite Biomedical is ... Read More
-
Advanced Marker Discovery SL - Product Pipeline Analysis, 2023 Update
... that support the physician’s decisions about patient management. Amadix provides discovery, clinical validation, assay development, clinical utility, commercialization, in licensing and out licensing services. The company identifies, evaluates and in-licenses breakthrough discoveries in cancer diagnosis ... Read More
-
CPSI Biotech - Product Pipeline Analysis, 2023 Update
... support of diverse clinical and research applications, devices and intellectual property for commercialization ventures among others. Its products find their application in cancer, cardiovascular disease treatments and cell therapy bioprocessing. CPSI is headquartered in Owego, ... Read More
-
ClearNote Health - Product Pipeline Analysis, 2023 Update
... cancer development. ClearNote non-invasive liquid biopsy technologies detect changes in specific organs, identify biological activity and gene expression, improve therapy selection and safety monitoring and evaluate individual’s organ systems and biological functions. It also carries ... Read More
Research Assistance
